New treatment for diabetes is now available
New treatment for adults with type 2 diabetes
Dapagliflozin (Forxiga), a new once-daily tablet to improve blood glucose control for adults with type 2 diabetes, has been granted Marketing Authorisation by the European Commission. This treatment is for use in combination with other glucose lowering treatments, including insulin when these, together with diet and exercise, do not provide adequate blood glucose control in patients.
Urgent support needed for “silent minority” of diabetes patients
A leading diabetes expert has called for urgent support for the “silent minority” in care homes to avoid unnecessary suffering and even premature deaths. More than a quarter of care home residents already have diabetes, which can be more difficult to manage in older people because of other linked disorders or diseases and their treatments.
Poor standards in diabetes
The National Audit Office has issued a report that concludes that diabetes services in England are not delivering value for money. It is estimated that up to 24,000 people die each year from avoidable causes related to their diabetes. The report concluded that with better management of people with diabetes, the NHS could save £170 million a year.
Diabesity: new epidemic
The rapid increase in the prevalence of type 2 diabetes and obesity, coined by experts as “diabesity”, has led to diabesity being recognised as an epidemic in Europe. A new UK survey of 300 GPs and nurses and 1,001 individuals with type 2 diabetes and obesity funded by Bristol Myers-Squibb and AstraZeneca, found that both healthcare professionals and patients agreed that controlling weight is the most challenging aspect of type 2 diabetes management.